| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/04/1997 | EP0776161A1 A method of selectively destroying neoplastic cells |
| 06/04/1997 | EP0716658B1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars |
| 06/04/1997 | EP0692967A4 Method of inhibiting radiation induced weight and hair loss |
| 06/04/1997 | EP0672119A4 Retroviral mediated transfer of the human multiple drug resistance gene. |
| 06/04/1997 | EP0621784B1 An iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 06/04/1997 | EP0598790B1 Somatotropin for increasing reproductivite performance in cattle |
| 06/04/1997 | EP0552269B1 Platelet adhesion inhibitor |
| 06/04/1997 | EP0527802B1 Ligand for the neu gene product |
| 06/04/1997 | CN1151186A Thymidine kinase mutants |
| 06/04/1997 | CN1151184A Human Monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 06/04/1997 | CN1151168A Method and compositions for the dry powder formulation of interferons |
| 06/04/1997 | CN1151167A Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 06/04/1997 | CN1151166A 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors |
| 06/04/1997 | CN1151156A Isoprenyl transferase inhibitors |
| 06/04/1997 | CN1151120A Method and compositions useful for inhibition of angiogenesis |
| 06/04/1997 | CN1151119A Medical use of bromelain |
| 06/04/1997 | CN1151116A Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/03/1997 | US5635765 Semiconductors having first and second refractory metal silicide layers which have differing stoichiometries |
| 06/03/1997 | US5635616 Human oxalyl-CoA decarboxylase |
| 06/03/1997 | US5635615 High affinity HIV nucleocapsid nucleic acid ligands |
| 06/03/1997 | US5635603 Antibody fragment covalently bound to diagnostic or therapeutic principle through carbohydrate moiety |
| 06/03/1997 | US5635600 Bifunctional and heteroantibodies specific for the high affinity Fc receptor for immunoglobulin G on human mononuclear phagocytes |
| 06/03/1997 | US5635599 Circularly permuted il4, il2, granulocyte macrophage colony stimulating factor or granulocyte colony stimulating factor fused to a cytotoxin, i.e., pseudomonas exotoxin, diphtheria toxin without the native receptor-binding domain; cancer |
| 06/03/1997 | US5635598 Selectively cleavabe linners based on iminodiacetic acid esters for solid phase peptide synthesis |
| 06/03/1997 | US5635597 Peptides that bind IL-2 receptors |
| 06/03/1997 | US5635594 Gallinacins - antibiotic peptides |
| 06/03/1997 | US5635593 Bradykinin antagonists |
| 06/03/1997 | US5635533 Antitumor agents |
| 06/03/1997 | US5635532 Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia |
| 06/03/1997 | US5635523 Retroviral protease inhibiting compounds |
| 06/03/1997 | US5635515 Administering cinchonine and/or hydroquinidine |
| 06/03/1997 | US5635512 Method for modifying or resetting the prolactin rhythm of an insulin insensitive or diabetic animal or human |
| 06/03/1997 | US5635504 Diazepine containing dual action inhibitors |
| 06/03/1997 | US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| 06/03/1997 | US5635489 Methods of prevention of oral mucositis with transforming growth factor β |
| 06/03/1997 | US5635484 Propionibacteria peptide microcin |
| 06/03/1997 | US5635483 Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| 06/03/1997 | US5635482 Synthetic compounds and compositions with enhanced cell binding |
| 06/03/1997 | US5635481 Administering blood-coagulation factor xai; also for treatment of inflammation and restenosis |
| 06/03/1997 | US5635480 Bacillus thuringiensis isolates and toxins |
| 06/03/1997 | US5635479 Anticarginic agents, ovarian cancer |
| 06/03/1997 | US5635478 Use of calcitonin gene-related peptide to regulate immune response |
| 06/03/1997 | US5635477 Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA |
| 06/03/1997 | US5635475 Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 06/03/1997 | US5635473 Inhibitor of hepatitis B virus replication |
| 06/03/1997 | US5635399 Retroviral vectors expressing cytokines |
| 06/03/1997 | US5635388 Monoclonal antibody produced by a hybridoma cell binds to the extracellular domain of flk2/flk3 and activates the intracellular tyrosine kinase domain enhancing repopulation of myeloid and lymphoid blood cell lineages with cytokines |
| 06/03/1997 | US5635385 Multi-unit ribozyme inhibition of oncogene gene expression |
| 06/03/1997 | US5635379 Prepared from n-alpha-acetyl-2-alkyl tryptophan racemic mixture |
| 06/03/1997 | US5635374 Bone calcification factor and recombinant production of the factor nucleic acid encoding |
| 06/03/1997 | US5635373 Bone morphogenic protein-5(BMP-5) and DNA encoding same |
| 06/03/1997 | US5635372 BMP-15 compositions |
| 06/03/1997 | US5635363 Compositions and methods for the detection, quantitation and purification of antigen-specific T cells |
| 06/03/1997 | US5635356 Anti-oncoimmunin-M antibodies and uses thereof |
| 06/03/1997 | US5635216 Stable biocompatible, biodegradable polyester matrices containing dispersion of water soluble polypeptide hormones |
| 06/03/1997 | US5635215 Hydrophilic acrylic copolymer coated with cell adhesion promoter |
| 06/03/1997 | US5635178 Inhibition of complement mediated inflammatory response using monoclonal antibodies specific for a component forming the C56-9 complex which inhibit the platelet or endothelial cell activating function of the C56-9 complex |
| 06/03/1997 | US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation |
| 06/03/1997 | US5635176 Pharmaceutical compositions containing IL-6 |
| 06/03/1997 | US5635175 Treatment of herpes and cytomegalo viruses |
| 06/03/1997 | US5635158 Peptides modified by the phosphine group for marking with 99M TC and 186-188 RE or paramagnetic agents |
| 06/03/1997 | CA2077651C Peptides stimulating cytotoxic t cells immune to hiv rt |
| 05/29/1997 | WO1997019194A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE |
| 05/29/1997 | WO1997019183A2 Tissue-specific transcription of dna sequence encoding a heterologous enzyme for use in prodrug therapy to lung cancer |
| 05/29/1997 | WO1997019180A2 Vector consisting of a transcriptional regulatory dna sequence linked to a dna sequence encoding beta-lactamase for enzyme prodrug therapy |
| 05/29/1997 | WO1997019179A1 Pseudomonas exotoxin - myelin basic protein chimeric proteins |
| 05/29/1997 | WO1997019177A1 SYNTHETIC MAMMALIAN α-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME |
| 05/29/1997 | WO1997019174A1 Virus protein antigens of the jc virus |
| 05/29/1997 | WO1997019173A1 Method of treating sepsis |
| 05/29/1997 | WO1997019172A1 Differentiation-suppressive polypeptide |
| 05/29/1997 | WO1997019170A1 Receptor and nucleic acid molecule encoding said receptor |
| 05/29/1997 | WO1997019169A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | WO1997019168A1 Sequestrin |
| 05/29/1997 | WO1997019113A2 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 05/29/1997 | WO1997019111A2 Monoclonal antibodies anti-cd6 and their uses |
| 05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | WO1997019108A1 Pulmonary surfactant peptide solubilization process |
| 05/29/1997 | WO1997019104A1 Cyclopeptolides |
| 05/29/1997 | WO1997019102A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 05/29/1997 | WO1997019101A1 Novel grb2 associating polypeptides and nucleic acids encoding therefor |
| 05/29/1997 | WO1997019098A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
| 05/29/1997 | WO1997019097A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018836A1 Virus replication inhibitor |
| 05/29/1997 | WO1997018835A1 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 05/29/1997 | WO1997018834A1 Therapeutic fragments of von willebrand factor |
| 05/29/1997 | WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | WO1997018832A1 Interferon-polymer conjugates and process for preparing the same |
| 05/29/1997 | WO1997018831A1 Endothelial cell protective |
| 05/29/1997 | WO1997018830A1 USE OF INTERFERON-β FOR TREATING BRONCHIAL CARCINOMA DURING RADIATION THERAPY |
| 05/29/1997 | WO1997018829A1 Cartilage/bone inducing materials for reparation |
| 05/29/1997 | WO1997018828A1 Inhibitors of cyclophilin rotamase activity |
| 05/29/1997 | WO1997018827A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | WO1997018826A1 Fine tuned protegrins |
| 05/29/1997 | WO1997018825A1 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | WO1997018805A1 Combinational therapeutic methods employing nitric oxide scavengers |
| 05/29/1997 | WO1997018799A1 Use of a tnf alpha antagonist for treating neurogenic skin redness |
| 05/29/1997 | WO1997018774A1 Method of treating involuntary muscle dysfunction with relaxin hormone |